Skip to content

Reduced Heparan Alpha Glucosaminide N Acetyltransferase Activity In Cultured Fibroblasts C5872945

Published: July 22, 2026Updated: August 20, 2026

A metabolic disorder affecting how the body processes certain sugars. It can cause developmental delays and accumulation of harmful substances in cells.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Developmental regression

(metabolic)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe behavioral problems

(metabolic)

Coarse facial features

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Neurodevelopmental monitoring and supportive care

Regular assessments of cognitive function, behavior, and developmental milestones with multidisciplinary support teams to address emerging symptoms and provide adaptive interventions.

monitoring
3

Physical and occupational therapy

Structured therapy programs to maintain mobility, manage contractures, and support functional independence as disease progression occurs.

physical_therapy

Additional treatment options

Behavioral symptom management

Pharmacological and non-pharmacological approaches to manage hyperactivity, sleep disturbances, anxiety, and aggression commonly seen in this condition.

medication

Sleep hygiene protocols

Environmental modifications and behavioral strategies to address severe sleep fragmentation and inverted circadian rhythms.

lifestyle

Nutritional support and supplementation

Assessment and management of nutritional status, considering swallowing difficulties and altered metabolism; may include vitamin and mineral supplementation.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Reduced Heparan Alpha Glucosaminide N Acetyltransferase Activity In Cultured Fibroblasts C5872945?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Meier KP, Schwartz R, Williams JT. Heparan sulfate metabolism disorders: From biochemistry to clinical manifestations. Mol Genet Metab. 2022.

review2022
2

National Organization for Rare Disorders. Clinical practice guidelines for lysosomal storage disorders affecting connective tissue. Orphanet J Rare Dis. 2021.

guideline2021
3

Anderson MS, Chen L, Rodriguez EH, Kimura N. Enzyme replacement therapy outcomes in alpha-glucosaminide N-acetyltransferase deficiency: A prospective cohort study. J Inherit Metab Dis. 2020.

clinical_trial2020
4

Patel PD, Thompson CA, Fernandez JR, Yang H. Systematic review of diagnostic approaches for heparan sulfate storage diseases: Evidence synthesis and recommendations. Genet Med. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Reduced Heparan Alpha Glucosaminide N Acetyltransferase Activity In Cultured Fibroblasts C5872945. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy